Profile data is unavailable for this security.
About the company
Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are the research, development, design, production and sales of drug molecular building blocks. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The Company conducts business in Asia Pacific, India, Europe, the United States and other regions.
- Revenue in CNY (TTM)1.10bn
- Net income in CNY77.60m
- Incorporated2007
- Employees846.00
- LocationBide Pharmatech Co LtdShanghai 200433ChinaCHN
- Phone+86 2 161601560
- Fax+86 2 161629029
- Websitehttps://www.bidepharmatech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 398.37m | 22.63m | 2.20bn | 787.00 | 96.96 | 3.00 | -- | 5.51 | 0.0593 | 0.0593 | 1.04 | 1.92 | 0.3728 | 1.48 | 1.87 | 506,185.00 | 2.12 | -4.59 | 2.99 | -6.24 | 47.94 | 24.09 | 5.68 | -18.40 | 1.43 | -- | 0.067 | -- | 5.54 | -2.50 | 137.33 | -- | -21.00 | -- |
| Qingdao Vland Biotech INC | 1.26bn | 78.59m | 2.65bn | 1.57k | 33.63 | 1.55 | -- | 2.10 | 0.3116 | 0.3116 | 5.01 | 6.77 | 0.432 | 3.49 | 4.07 | 804,705.90 | 3.70 | 5.78 | 5.78 | 7.89 | 45.41 | 46.13 | 8.57 | 10.34 | 0.8687 | 22.88 | 0.3127 | 33.59 | 3.07 | 8.05 | 15.56 | -0.6507 | 24.68 | -6.89 |
| Bide Pharmatech Co Ltd | 1.10bn | 77.60m | 2.72bn | 846.00 | 34.51 | 1.38 | -- | 2.47 | 0.8669 | 0.8669 | 12.25 | 21.73 | 0.4687 | 1.02 | 4.83 | 1,301,939.00 | 3.26 | -- | 3.73 | -- | 38.92 | -- | 6.96 | -- | 5.04 | -- | 0.043 | -- | 30.94 | -- | -24.94 | -- | -- | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 455.90m | 102.18m | 2.78bn | 566.00 | 22.81 | 2.71 | -- | 6.10 | 0.4397 | 0.4397 | 1.82 | 3.70 | 0.2866 | 0.3598 | 8.66 | 805,473.80 | 6.79 | 8.83 | 7.81 | 9.61 | 61.34 | 61.49 | 23.70 | 26.85 | 3.13 | -- | 0.2729 | 45.71 | 6.55 | 19.36 | -7.48 | 9.95 | 31.41 | -- |
| Jiangsu Yahong Meditech Co Ltd | 94.17m | -398.99m | 2.90bn | 394.00 | -- | 1.32 | -- | 30.81 | -0.6969 | -0.6969 | 0.1645 | 3.85 | 0.0366 | 11.12 | 5.92 | 239,007.60 | -15.55 | -15.80 | -16.49 | -16.48 | 77.85 | 55.32 | -424.48 | -9,445.91 | 10.12 | -- | 0.0711 | -- | 52,594.79 | -- | -62.42 | -- | 64.28 | -- |
| Hinova Pharmaceuticals Inc | 109.74k | -229.37m | 3.16bn | 179.00 | -- | 2.47 | -- | 28,818.65 | -2.32 | -2.32 | 0.0011 | 12.92 | 0.00007 | 7.25 | 0.0054 | 613.07 | -14.92 | -31.86 | -16.50 | -37.18 | -400.96 | -- | -209,012.60 | -25,578.24 | 7.21 | -- | 0.036 | -- | -100.00 | -- | 2.44 | -- | 124.37 | -- |
| Shanghai Medicilon Inc | 1.01bn | -269.57m | 3.34bn | 2.42k | -- | 1.37 | -- | 3.29 | -2.01 | -2.01 | 7.68 | 18.05 | 0.365 | 6.19 | 1.32 | 390,279.00 | -9.70 | 9.34 | -12.49 | 11.73 | 1.81 | 36.71 | -26.57 | 14.93 | 2.87 | -- | 0.0923 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| Beijing Kawin Technol Sha-hld Co Ltd | 1.44bn | 120.57m | 3.35bn | 584.00 | 27.25 | 1.87 | -- | 2.33 | 0.7192 | 0.7192 | 8.56 | 10.48 | 0.6254 | 1.58 | 3.70 | 2,465,474.00 | 6.48 | 5.31 | 8.22 | 6.76 | 83.02 | 86.02 | 10.36 | 8.10 | 3.22 | -- | 0.103 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.03bn | 215.33m | 3.38bn | 1.39k | 15.68 | 3.10 | -- | 3.27 | 1.92 | 1.92 | 9.23 | 9.73 | 0.5919 | 32.80 | 1.65 | 754,698.20 | 11.73 | 12.99 | 18.65 | 21.70 | 56.06 | 53.93 | 19.82 | 21.34 | 1.98 | 35.78 | 0.3065 | 10.74 | 37.76 | 47.22 | 18.08 | 54.90 | 34.77 | -- |
| HitGen Inc | 410.39m | 45.10m | 3.47bn | 452.00 | 76.60 | 2.56 | -- | 8.45 | 0.1129 | 0.1129 | 1.03 | 3.38 | 0.2418 | 7.22 | 5.05 | 907,947.10 | 2.60 | 4.63 | 2.76 | 5.10 | 49.20 | 58.89 | 10.77 | 20.66 | 16.53 | 24.49 | 0.1431 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
Data as of Sep 13 2024. Currency figures normalised to Bide Pharmatech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
16.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 3.72m | 9.95% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 598.19k | 1.60% |
| ABC-CA Fund Management Co., Ltd.as of 31 Dec 2023 | 354.57k | 0.95% |
| Huisheng Fund Management Co., Ltd.as of 31 Dec 2023 | 296.43k | 0.79% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 263.01k | 0.70% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 200.88k | 0.54% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 196.62k | 0.53% |
| Focusbridge Investments Ltd.as of 31 Dec 2023 | 193.96k | 0.52% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 31 Dec 2023 | 193.29k | 0.52% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 148.39k | 0.40% |
More ▼
Data from 31 Dec 2023 - 12 Sep 2024Source: FactSet Research Systems Inc.
